Compounds > mibefradil
Page last updated: 2024-08-24

mibefradil and carboplatin

mibefradil has been researched along with carboplatin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casarez, EV; Dziegielewska, B; Dziegielewski, J; Gray, LS; Slack-Davis, JK; Yang, WZ1

Other Studies

1 other study(ies) available for mibefradil and carboplatin

ArticleYear
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium Channel Blockers; Calcium Channels, T-Type; Carboplatin; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Inhibitor of Apoptosis Proteins; Mibefradil; Mice; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Survivin; Transcription, Genetic; Xenograft Model Antitumor Assays

2016